Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Share-based Compensation (2016 - 2025)

CorMedix has reported Share-based Compensation over the past 14 years, most recently at $3.6 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $3.6 million for Q4 2025, up 200.71% from a year ago — trailing twelve months through Dec 2025 was $13.8 million (up 125.68% YoY), and the annual figure for FY2025 was $13.8 million, up 125.68%.
  • Share-based Compensation reached $3.6 million in Q4 2025 per CRMD's latest filing, down from $4.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.1 million in Q3 2025 and bottomed at $50000.0 in Q2 2022.
  • Median Share-based Compensation over the past 5 years was $1.2 million (2023), compared with a mean of $1.7 million.
  • The largest annual shift saw Share-based Compensation tumbled 95.05% in 2022 before it skyrocketed 1878.0% in 2023.
  • Over 5 years, Share-based Compensation stood at $1.3 million in 2021, then crashed by 30.26% to $874051.0 in 2022, then surged by 39.27% to $1.2 million in 2023, then fell by 1.95% to $1.2 million in 2024, then surged by 200.71% to $3.6 million in 2025.
  • Business Quant data shows Share-based Compensation for CRMD at $3.6 million in Q4 2025, $4.1 million in Q3 2025, and $2.7 million in Q2 2025.